Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod...

Today's Daily Dose brings you news about the clinical hold imposed by the FDA on Merck's trials; CSL Limited evincing interest for a Swiss based biotech, Atara's ALLELE trial results, FDA approval of Veru's ENTADFI and the Leukemia & Lymphoma Society's findings regarding the need for a third primary dose of mRNA COVID-19 vaccine for blood cancer patients.